Us Renal Care Vineland Dialysis in Vineland, New Jersey - Dialysis Center

Us Renal Care Vineland Dialysis is a medicare approved dialysis facility center in Vineland, New Jersey and it has 21 dialysis stations. It is located in Cumberland county at 1450 East Chestnut Ave Suite 2c, Vineland, NJ, 08361. You can reach out to the office of Us Renal Care Vineland Dialysis at (856) 692-9060. This dialysis clinic is managed and/or owned by Us Renal Care, Inc.. Us Renal Care Vineland Dialysis has the following ownership type - Profit. It was first certified by medicare in February, 2000. The medicare id for this facility is 312551 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameUs Renal Care Vineland Dialysis
Location1450 East Chestnut Ave Suite 2c, Vineland, New Jersey
No. of Dialysis Stations 21
Medicare ID312551
Managed ByUs Renal Care, Inc.
Ownership TypeProfit
Late Shifts No

Contact Information


1450 East Chestnut Ave Suite 2c, Vineland, New Jersey, 08361
(856) 692-9060

News Archive

NASA software could help interpret medical imagery

NASA software used to enhance Earth science imagery could help interpret medical imagery. The new MED-SEG system, developed by Bartron Medical Imaging Inc. of Largo, Md., relies on an innovative software program developed at NASA to help doctors analyze mammograms, ultrasounds, digital X-rays and other medical imaging tests.

Polls show stable attitudes on public option, abortion

A Bloomberg poll conducted Dec. 3-7 found, on health care, "about half of poll respondents saying they disapprove of the plans in Congress to overhaul the system. Sixty-two percent of Americans say they are mostly pessimistic they would benefit from [a health-care bill Congress may pass.] The youngest Americans are more optimistic, with 47 percent of those under 35 saying they would benefit."

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

Six common myths about prostate cancer

When it comes to prostate cancer, there's a lot of confusion about how to prevent it, find it early and the best way - or even whether - to treat it. Below are six common prostate cancer myths along with research-based information from scientists at Fred Hutchinson Cancer Research Center to help men separate fact from fiction.

Social, metacognition deficits in schizophrenia predict dysfunction type

Research findings suggest that deficits in social cognition and metacognition among individuals with schizophrenia represent different forms of dysfunction and symptomatology.

Read more Medical News

› Verified 7 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Us Renal Care Vineland Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1033172457
Organization NameU S Renal Care Vineland Dialysis
Doing Business AsDca Of Vineland Llc
Address1450 E Chestnut Ave Vineland, New Jersey, 08361
Phone Number(856) 692-9060

News Archive

NASA software could help interpret medical imagery

NASA software used to enhance Earth science imagery could help interpret medical imagery. The new MED-SEG system, developed by Bartron Medical Imaging Inc. of Largo, Md., relies on an innovative software program developed at NASA to help doctors analyze mammograms, ultrasounds, digital X-rays and other medical imaging tests.

Polls show stable attitudes on public option, abortion

A Bloomberg poll conducted Dec. 3-7 found, on health care, "about half of poll respondents saying they disapprove of the plans in Congress to overhaul the system. Sixty-two percent of Americans say they are mostly pessimistic they would benefit from [a health-care bill Congress may pass.] The youngest Americans are more optimistic, with 47 percent of those under 35 saying they would benefit."

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

Six common myths about prostate cancer

When it comes to prostate cancer, there's a lot of confusion about how to prevent it, find it early and the best way - or even whether - to treat it. Below are six common prostate cancer myths along with research-based information from scientists at Fred Hutchinson Cancer Research Center to help men separate fact from fiction.

Social, metacognition deficits in schizophrenia predict dysfunction type

Research findings suggest that deficits in social cognition and metacognition among individuals with schizophrenia represent different forms of dysfunction and symptomatology.

Read more Medical News

› Verified 7 days ago


Survey of Patient's Experiences

Nephrologists Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that nephrologists always communicated and cared for them.59%67%
Patients who reported that nephrologists usually communicated and cared for them.16%15%
Patients who reported that nephrologists sometimes or never communicated and cared for them.25%18%
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).50%60%
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).25%26%
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).25%14%

News Archive

NASA software could help interpret medical imagery

NASA software used to enhance Earth science imagery could help interpret medical imagery. The new MED-SEG system, developed by Bartron Medical Imaging Inc. of Largo, Md., relies on an innovative software program developed at NASA to help doctors analyze mammograms, ultrasounds, digital X-rays and other medical imaging tests.

Polls show stable attitudes on public option, abortion

A Bloomberg poll conducted Dec. 3-7 found, on health care, "about half of poll respondents saying they disapprove of the plans in Congress to overhaul the system. Sixty-two percent of Americans say they are mostly pessimistic they would benefit from [a health-care bill Congress may pass.] The youngest Americans are more optimistic, with 47 percent of those under 35 saying they would benefit."

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

Six common myths about prostate cancer

When it comes to prostate cancer, there's a lot of confusion about how to prevent it, find it early and the best way - or even whether - to treat it. Below are six common prostate cancer myths along with research-based information from scientists at Fred Hutchinson Cancer Research Center to help men separate fact from fiction.

Social, metacognition deficits in schizophrenia predict dysfunction type

Research findings suggest that deficits in social cognition and metacognition among individuals with schizophrenia represent different forms of dysfunction and symptomatology.

Read more Medical News

› Verified 7 days ago

Dialysis Center Staff Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible.62%62%
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible.16%20%
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free.22%18%
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).58%62%
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).30%26%
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).12%12%

News Archive

NASA software could help interpret medical imagery

NASA software used to enhance Earth science imagery could help interpret medical imagery. The new MED-SEG system, developed by Bartron Medical Imaging Inc. of Largo, Md., relies on an innovative software program developed at NASA to help doctors analyze mammograms, ultrasounds, digital X-rays and other medical imaging tests.

Polls show stable attitudes on public option, abortion

A Bloomberg poll conducted Dec. 3-7 found, on health care, "about half of poll respondents saying they disapprove of the plans in Congress to overhaul the system. Sixty-two percent of Americans say they are mostly pessimistic they would benefit from [a health-care bill Congress may pass.] The youngest Americans are more optimistic, with 47 percent of those under 35 saying they would benefit."

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

Six common myths about prostate cancer

When it comes to prostate cancer, there's a lot of confusion about how to prevent it, find it early and the best way - or even whether - to treat it. Below are six common prostate cancer myths along with research-based information from scientists at Fred Hutchinson Cancer Research Center to help men separate fact from fiction.

Social, metacognition deficits in schizophrenia predict dysfunction type

Research findings suggest that deficits in social cognition and metacognition among individuals with schizophrenia represent different forms of dysfunction and symptomatology.

Read more Medical News

› Verified 7 days ago

Overall Dialysis Center Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. 81%80%
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them.19%20%
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).61%68%
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).22%20%
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).17%12%

News Archive

NASA software could help interpret medical imagery

NASA software used to enhance Earth science imagery could help interpret medical imagery. The new MED-SEG system, developed by Bartron Medical Imaging Inc. of Largo, Md., relies on an innovative software program developed at NASA to help doctors analyze mammograms, ultrasounds, digital X-rays and other medical imaging tests.

Polls show stable attitudes on public option, abortion

A Bloomberg poll conducted Dec. 3-7 found, on health care, "about half of poll respondents saying they disapprove of the plans in Congress to overhaul the system. Sixty-two percent of Americans say they are mostly pessimistic they would benefit from [a health-care bill Congress may pass.] The youngest Americans are more optimistic, with 47 percent of those under 35 saying they would benefit."

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

Six common myths about prostate cancer

When it comes to prostate cancer, there's a lot of confusion about how to prevent it, find it early and the best way - or even whether - to treat it. Below are six common prostate cancer myths along with research-based information from scientists at Fred Hutchinson Cancer Research Center to help men separate fact from fiction.

Social, metacognition deficits in schizophrenia predict dysfunction type

Research findings suggest that deficits in social cognition and metacognition among individuals with schizophrenia represent different forms of dysfunction and symptomatology.

Read more Medical News

› Verified 7 days ago

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data73
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL8

News Archive

NASA software could help interpret medical imagery

NASA software used to enhance Earth science imagery could help interpret medical imagery. The new MED-SEG system, developed by Bartron Medical Imaging Inc. of Largo, Md., relies on an innovative software program developed at NASA to help doctors analyze mammograms, ultrasounds, digital X-rays and other medical imaging tests.

Polls show stable attitudes on public option, abortion

A Bloomberg poll conducted Dec. 3-7 found, on health care, "about half of poll respondents saying they disapprove of the plans in Congress to overhaul the system. Sixty-two percent of Americans say they are mostly pessimistic they would benefit from [a health-care bill Congress may pass.] The youngest Americans are more optimistic, with 47 percent of those under 35 saying they would benefit."

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

Six common myths about prostate cancer

When it comes to prostate cancer, there's a lot of confusion about how to prevent it, find it early and the best way - or even whether - to treat it. Below are six common prostate cancer myths along with research-based information from scientists at Fred Hutchinson Cancer Research Center to help men separate fact from fiction.

Social, metacognition deficits in schizophrenia predict dysfunction type

Research findings suggest that deficits in social cognition and metacognition among individuals with schizophrenia represent different forms of dysfunction and symptomatology.

Read more Medical News

› Verified 7 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center100
    Adult patient months included in Kt/V greater than or equal to 1.2873
    Percentage of adult patients getting regular hemodialysis at the center97
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    NASA software could help interpret medical imagery

    NASA software used to enhance Earth science imagery could help interpret medical imagery. The new MED-SEG system, developed by Bartron Medical Imaging Inc. of Largo, Md., relies on an innovative software program developed at NASA to help doctors analyze mammograms, ultrasounds, digital X-rays and other medical imaging tests.

    Polls show stable attitudes on public option, abortion

    A Bloomberg poll conducted Dec. 3-7 found, on health care, "about half of poll respondents saying they disapprove of the plans in Congress to overhaul the system. Sixty-two percent of Americans say they are mostly pessimistic they would benefit from [a health-care bill Congress may pass.] The youngest Americans are more optimistic, with 47 percent of those under 35 saying they would benefit."

    GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

    GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

    Six common myths about prostate cancer

    When it comes to prostate cancer, there's a lot of confusion about how to prevent it, find it early and the best way - or even whether - to treat it. Below are six common prostate cancer myths along with research-based information from scientists at Fred Hutchinson Cancer Research Center to help men separate fact from fiction.

    Social, metacognition deficits in schizophrenia predict dysfunction type

    Research findings suggest that deficits in social cognition and metacognition among individuals with schizophrenia represent different forms of dysfunction and symptomatology.

    Read more Medical News

    › Verified 7 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center28
    Adult patient months included in Kt/V greater than or equal to 1.7246
    Percentage of adult patients getting regular peritoneal dialysis at the center85
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    NASA software could help interpret medical imagery

    NASA software used to enhance Earth science imagery could help interpret medical imagery. The new MED-SEG system, developed by Bartron Medical Imaging Inc. of Largo, Md., relies on an innovative software program developed at NASA to help doctors analyze mammograms, ultrasounds, digital X-rays and other medical imaging tests.

    Polls show stable attitudes on public option, abortion

    A Bloomberg poll conducted Dec. 3-7 found, on health care, "about half of poll respondents saying they disapprove of the plans in Congress to overhaul the system. Sixty-two percent of Americans say they are mostly pessimistic they would benefit from [a health-care bill Congress may pass.] The youngest Americans are more optimistic, with 47 percent of those under 35 saying they would benefit."

    GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

    GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

    Six common myths about prostate cancer

    When it comes to prostate cancer, there's a lot of confusion about how to prevent it, find it early and the best way - or even whether - to treat it. Below are six common prostate cancer myths along with research-based information from scientists at Fred Hutchinson Cancer Research Center to help men separate fact from fiction.

    Social, metacognition deficits in schizophrenia predict dysfunction type

    Research findings suggest that deficits in social cognition and metacognition among individuals with schizophrenia represent different forms of dysfunction and symptomatology.

    Read more Medical News

    › Verified 7 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Us Renal Care Vineland Dialysis with elevated calcium levels.

Patients with hypercalcemia130
Hypercalcemia patient months1143
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor138
Patients with Serumphosphor less than 3.5 mg/dL12
Patients with Serumphosphor from 3.5 to 4.5 mg/dL28
Patients with Serumphosphor from 4.6 to 5.5 mg/dL33
Patients with Serumphosphor from 5.6 to 7 mg/dL19
Patients with Serumphosphor greater than 7 mg/dL8

News Archive

NASA software could help interpret medical imagery

NASA software used to enhance Earth science imagery could help interpret medical imagery. The new MED-SEG system, developed by Bartron Medical Imaging Inc. of Largo, Md., relies on an innovative software program developed at NASA to help doctors analyze mammograms, ultrasounds, digital X-rays and other medical imaging tests.

Polls show stable attitudes on public option, abortion

A Bloomberg poll conducted Dec. 3-7 found, on health care, "about half of poll respondents saying they disapprove of the plans in Congress to overhaul the system. Sixty-two percent of Americans say they are mostly pessimistic they would benefit from [a health-care bill Congress may pass.] The youngest Americans are more optimistic, with 47 percent of those under 35 saying they would benefit."

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

Six common myths about prostate cancer

When it comes to prostate cancer, there's a lot of confusion about how to prevent it, find it early and the best way - or even whether - to treat it. Below are six common prostate cancer myths along with research-based information from scientists at Fred Hutchinson Cancer Research Center to help men separate fact from fiction.

Social, metacognition deficits in schizophrenia predict dysfunction type

Research findings suggest that deficits in social cognition and metacognition among individuals with schizophrenia represent different forms of dysfunction and symptomatology.

Read more Medical News

› Verified 7 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 89
Patient months included in arterial venous fistula and catheter summaries 799
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment65
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer8

News Archive

NASA software could help interpret medical imagery

NASA software used to enhance Earth science imagery could help interpret medical imagery. The new MED-SEG system, developed by Bartron Medical Imaging Inc. of Largo, Md., relies on an innovative software program developed at NASA to help doctors analyze mammograms, ultrasounds, digital X-rays and other medical imaging tests.

Polls show stable attitudes on public option, abortion

A Bloomberg poll conducted Dec. 3-7 found, on health care, "about half of poll respondents saying they disapprove of the plans in Congress to overhaul the system. Sixty-two percent of Americans say they are mostly pessimistic they would benefit from [a health-care bill Congress may pass.] The youngest Americans are more optimistic, with 47 percent of those under 35 saying they would benefit."

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

Six common myths about prostate cancer

When it comes to prostate cancer, there's a lot of confusion about how to prevent it, find it early and the best way - or even whether - to treat it. Below are six common prostate cancer myths along with research-based information from scientists at Fred Hutchinson Cancer Research Center to help men separate fact from fiction.

Social, metacognition deficits in schizophrenia predict dysfunction type

Research findings suggest that deficits in social cognition and metacognition among individuals with schizophrenia represent different forms of dysfunction and symptomatology.

Read more Medical News

› Verified 7 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary111
Hospitalization Rate in facility143.3 (As Expected)
Hospitalization Rate: Upper Confidence Limit238.9
Hospitalization Rate: Lower Confidence Limit92.9

News Archive

NASA software could help interpret medical imagery

NASA software used to enhance Earth science imagery could help interpret medical imagery. The new MED-SEG system, developed by Bartron Medical Imaging Inc. of Largo, Md., relies on an innovative software program developed at NASA to help doctors analyze mammograms, ultrasounds, digital X-rays and other medical imaging tests.

Polls show stable attitudes on public option, abortion

A Bloomberg poll conducted Dec. 3-7 found, on health care, "about half of poll respondents saying they disapprove of the plans in Congress to overhaul the system. Sixty-two percent of Americans say they are mostly pessimistic they would benefit from [a health-care bill Congress may pass.] The youngest Americans are more optimistic, with 47 percent of those under 35 saying they would benefit."

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

Six common myths about prostate cancer

When it comes to prostate cancer, there's a lot of confusion about how to prevent it, find it early and the best way - or even whether - to treat it. Below are six common prostate cancer myths along with research-based information from scientists at Fred Hutchinson Cancer Research Center to help men separate fact from fiction.

Social, metacognition deficits in schizophrenia predict dysfunction type

Research findings suggest that deficits in social cognition and metacognition among individuals with schizophrenia represent different forms of dysfunction and symptomatology.

Read more Medical News

› Verified 7 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Us Renal Care Vineland Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility35.8 (As Expected)
Readmission Rate: Upper Confidence Limit49.4
Readmission Rate: Lower Confidence Limit23.8

News Archive

NASA software could help interpret medical imagery

NASA software used to enhance Earth science imagery could help interpret medical imagery. The new MED-SEG system, developed by Bartron Medical Imaging Inc. of Largo, Md., relies on an innovative software program developed at NASA to help doctors analyze mammograms, ultrasounds, digital X-rays and other medical imaging tests.

Polls show stable attitudes on public option, abortion

A Bloomberg poll conducted Dec. 3-7 found, on health care, "about half of poll respondents saying they disapprove of the plans in Congress to overhaul the system. Sixty-two percent of Americans say they are mostly pessimistic they would benefit from [a health-care bill Congress may pass.] The youngest Americans are more optimistic, with 47 percent of those under 35 saying they would benefit."

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

Six common myths about prostate cancer

When it comes to prostate cancer, there's a lot of confusion about how to prevent it, find it early and the best way - or even whether - to treat it. Below are six common prostate cancer myths along with research-based information from scientists at Fred Hutchinson Cancer Research Center to help men separate fact from fiction.

Social, metacognition deficits in schizophrenia predict dysfunction type

Research findings suggest that deficits in social cognition and metacognition among individuals with schizophrenia represent different forms of dysfunction and symptomatology.

Read more Medical News

› Verified 7 days ago